Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-28 Exercise | 2024-02-29 4:29 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 67,400 | $0 | 255,742 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 4:29 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 24,353 | $2.62 | 255,742 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 407,620 | $0 | 407,620 (Direct) | View |
| 2023-02-28 Tax Withholding | 2023-03-01 4:51 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 19,118 | $2.17 | 181,825 (Direct) | View |
| 2023-02-28 Exercise | 2023-03-01 4:51 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 52,886 | $0 | 181,825 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 5:00 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 393,080 | $0 | 393,080 (Direct) | View |
| 2022-02-28 Tax Withholding | 2022-02-28 7:15 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 13,241 | $2.85 | 118,273 (Direct) | View |
| 2022-02-28 Exercise | 2022-02-28 7:15 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 36,628 | $0 | 118,273 (Direct) | View |
| 2022-02-10 Option Award | 2022-02-14 4:06 pm | N/A 2032-02-10 | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 330,680 | $0 | 330,680 (Direct) | View |
Ownership | 2021-10-01 4:05 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 0 | $0 | 409,675 (Direct) | View |